top of page
gradientForSurfBreak.png

Item List

Yahoo
Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of the Rare Patient Network expanding Invitae's Ciitizen platform to all patients with pediatric epilepsy and/or developmental delay with plans to include other conditions in the coming months. By engaging with a broader community, Invitae, a leader in the rare pediatric neurodevelopmental field, aims to create value for significantly more patients with rare diseases.

Recent Posts

Portfolio Company

Carlsmed.png

AI Used for Skin Cancer Checks at London Hospital
...

BBC

Portfolio Company

Carlsmed.png

CARTI Cancer Center Deploys DeepScribe's Ambient Operating System for Oncology ...

PR Newswire

Portfolio Company

Carlsmed.png

Ideem locks in $2.4M seed round for trust tech spinout driven by Toby Rush, star ...

Startland News

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page